![]() |
市場調查報告書
商品編碼
1822291
全球橫向流動化驗組件市場(按產品、技術、應用、最終用戶和地區分類)- 預測至 2030 年Lateral Flow Assay Components Market by Type (Membrane, Pad), Application (Clinical Testing (Infectious, Cardiac Marker Test, Fertility, Pregnancy, Cholesterol Testing), Veterinary, Food Safety), Technique, End User & Region - Global Forecast to 2030 |
全球橫向流動化驗(LFA) 組件市場預計將從 2025 年的 3.924 億美元成長到 2030 年的 4.862 億美元,預測期內複合年成長率為 4.4%。
調查範圍 | |
---|---|
調查年份 | 2024-2030 |
基準年 | 2024 |
預測期 | 2025-2030 |
對價單位 | 金額(十億美元) |
部分 | 按產品、技術、應用、最終用戶和地區 |
目標區域 | 北美、歐洲、亞太地區、拉丁美洲、中東和非洲、海灣合作理事會國家 |
近年來,受感染疾病疫情上升、就地檢驗需求成長以及家庭診斷普及率不斷提高等因素的推動,橫向流動化驗組件市場取得了顯著成長。膜、墊片及相關材料的不斷發展提高了檢測準確性,縮短了交付時間,使其在臨床、獸醫、食品安全和藥物開發領域的應用範圍不斷擴大。除了老牌企業外,越來越多的小型專業製造商正在主導材料設計和生產方法的創新,提供獨特的解決方案,以滿足最終用戶的多樣化需求。
橫向流動化驗組件市場分為夾心法、競爭性分析及多重偵測分析。其中,夾心法因其高靈敏度、特異性以及適用於檢測細菌病原體、病毒抗原和關鍵生物標記等大型分析物而在2024年佔據了最大的市場佔有率。此方法將分析物「夾」在兩種高度特異性的抗體之間,產生與分析物濃度直接相關的訊號,以獲得可靠的定量結果。夾心法在最常見的診斷測試中的應用進一步證明了其優越性,例如妊娠測試(人類絨毛膜促性腺激素 (HCG))、傳染病檢查(愛滋病毒、乙型肝炎、幽門螺旋桿菌)和心臟標記檢測(肌鈣蛋白、CK-MB、肌紅蛋白)。無論分析物濃度如何,夾心法都能產生持續強勁的對照線訊號,從而提高了測試的可靠性,這對於臨床和家庭診斷至關重要。隨著醫療保健提供者擴大採用即時診斷 (POC) 解決方案,針對夾心檢測方案量身定做的膜、結合墊片和奈米顆粒的需求持續成長。相較之下,競爭性檢測適用於具有單一抗原決定簇的小分子,並且在藥物濫用檢測和某些食品安全應用等領域仍然重要。同時,多重檢測方法因其能夠同時分析多個靶點而日益普及。然而,夾心檢測的廣泛臨床應用和成熟的診斷準確性才是全球市場組件消費的主要驅動力。
按最終用戶分類,橫向流動化驗組件市場可細分為醫療設備製造商和醫療設備契約製造製造商。由於醫療設備製造商在各種診斷設備的設計、工程和製造中發揮重要作用,預計到 2024 年他們將佔據市場主導地位並佔據主要佔有率。膜、墊、結合物和外殼材料的主要消費者包括雅培(美國)、霍夫曼羅氏(美國)、丹納赫集團(美國)、西門子醫療(美國)、 墊片 -Rad Laboratories(美國)、賽默飛世爾科技(美國)、珀金埃爾默(美國)、Hologic(美國)和默克集團(德國)。感染疾病的流行、老年人口的成長以及家庭和照護現場診斷的廣泛採用,正在推動 LFA 組件融入診斷產品系列。因此,醫療設備製造商是組件市場的主要需求驅動力。同時,醫療設備契約製造製造商是一個穩定成長的細分市場。隨著契約製造製造商 (OEM) 將生產外包以降低成本、快速擴充性並獲取專業知識,合約製造商已成為膜、墊片和其他耗材的重要買家。這一趨勢在亞太地區尤其明顯,該地區有利的人事費用和支持性的製造生態系統正在鼓勵跨國公司與本地生產商合作,進一步推動該地區對零件的需求。
全球橫向流動化驗組件市場分為五個區域:北美、歐洲、亞太、拉丁美洲以及中東和非洲。預計在預測期內,亞太地區將在橫向流動化驗組件市場中實現最高的複合年成長率,這得益於醫療保健的快速擴張、強勁的經濟成長以及國內外參與者不斷增加的投資。這一成長的主要驅動力包括中國、印度、日本、韓國、台灣、澳洲和新加坡等高成長國家和地區。醫療保健支出增加、人口老化、預期壽命延長以及對即時檢測和家庭檢測的需求增加等因素,正在推動對膜、結合墊片、金奈米顆粒和其他側流分析組件的需求。由於醫療保健基礎設施的不斷擴大、收入的不斷成長以及政府對診斷技術的重視,中國和印度仍然是最具影響力的市場。印度在2023-2024財政年度增加的醫療保健預算為這些努力提供了支持。同時,越南、印尼和菲律賓等東南亞國家憑藉著強勁的GDP成長、製造能力的提升以及外國投資,正成為新的成長中心。儘管存在這些成長動力,但諸如對近距離檢測益處的認知度低、報銷機制不完善以及農村和偏遠地區基礎設施缺口等挑戰,仍然是全面普及的障礙。然而,憑藉Advanced Microdevices Ltd.(印度)、J. Mitra, Inc.(印度)、J. Mitra & Co.(印度)、Nupore Filtration(中國)和Equinox(中國)等具有競爭力的本地製造商,以及跨國供應商的存在,該地區的LFA組件生態系統得以增強,並使其保持了成長最快的區域市場地位。
本報告研究了全球橫向流動化驗組件市場,按產品、技術、應用、最終用戶和地區進行細分,並提供了參與市場的公司概況。
The global lateral flow assay (LFA) components market is projected to reach USD 486.2 million by 2030 from USD 392.4 million in 2025, at a CAGR of 4.4% during the forecast period.
Scope of the Report | |
---|---|
Years Considered for the Study | 2024-2030 |
Base Year | 2024 |
Forecast Period | 2025-2030 |
Units Considered | Value (USD billion) |
Segments | Product, Application, Technique, Sample Type, and End User |
Regions covered | North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries |
In recent years, the lateral flow assay components market has gained significant momentum, driven by the increasing prevalence of infectious diseases, rising demand for point-of-care testing, and greater adoption of home-based diagnostics. Ongoing improvements in membranes, pads, and related materials have improved test accuracy and reduced turnaround times, expanding their use in clinical, veterinary, food safety, and drug development settings. Along with established companies, a growing number of small and specialized manufacturers are leading innovation in material design and production methods, offering unique solutions that meet diverse end-user needs and requirements.
"The sandwich assays segment of the lateral flow assay components market, by technique, is expected to hold the largest position during the forecast period."
The lateral flow assay components market is divided into sandwich assays, competitive assays, and multiplex detection assays. Among these, sandwich assays held the largest market share in 2024, due to their higher sensitivity, specificity, and suitability for detecting larger analytes like bacterial pathogens, viral antigens, and key biomarkers. In this method, the analyte is "sandwiched" between two highly specific antibodies, creating a signal that directly correlates with analyte concentration, ensuring reliable and quantitative results. The dominance of sandwich assays is further supported by their use in some of the most common diagnostic tests, including pregnancy testing (hCG), infectious disease testing (HIV, hepatitis B, H. pylori), and cardiac marker detection (troponin, CK-MB, myoglobin). Their ability to consistently produce strong control line signals, regardless of analyte levels, improves test reliability-a vital aspect for clinical and home-based diagnostics. As healthcare providers increasingly adopt point-of-care solutions, the demand for membranes, conjugate pads, and nanoparticles tailored to sandwich assay formats continues to grow. In contrast, competitive assays-more suitable for small molecules with a single antigenic determinant-remain important in areas like drug-of-abuse testing and certain food safety applications. Meanwhile, multiplex detection assays are gaining popularity for their capacity to analyze multiple targets simultaneously. Nevertheless, it is the extensive clinical applications and established diagnostic accuracy of sandwich assays that primarily drive the consumption of components worldwide market.
"The medical device manufacturing companies accounted for the largest market share in the lateral flow assay components market, by end user."
The lateral flow assay components market, by end user, is divided into medical device manufacturing companies and medical device contract manufacturing companies. Among these, medical device manufacturing companies led the market in 2024, holding the largest share because of their extensive role in designing, engineering, and producing a wide range of diagnostic devices. These companies, including Abbott (US), Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Siemens Healthineers (Germany), Bio-Rad Laboratories (US), Thermo Fisher Scientific (US), PerkinElmer (US), Hologic (US), and Merck KGaA (Germany), are the main consumers of membranes, pads, conjugates, and housing materials. The increasing prevalence of infectious diseases, the growing elderly population, and the rising adoption of home-based and point-of-care diagnostics have driven the integration of LFA components into diagnostic product portfolios. This has made medical device manufacturers the primary demand drivers in the component market. Meanwhile, medical device contract manufacturing companies form a steadily growing segment. As OEMs outsource production for cost savings, faster scalability, and access to specialized expertise, contract manufacturers are becoming important buyers of membranes, pads, and other consumables. This trend is especially strong in Asia-Pacific, where favorable labor costs and supportive manufacturing ecosystems encourage global companies to partner with local producers, further boosting demand for components from this segment.
"The Asia Pacific is the fastest-growing region of the lateral flow assay components market by region."
The global lateral flow assay components market is segmented into five segments, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to achieve the highest CAGR in the lateral flow assay components market during the forecast period, driven by rapid healthcare expansion, strong economic growth, and increasing investments from both domestic and international players. Key contributors to this growth include high-growth countries such as China, India, Japan, South Korea, Taiwan, Australia, and Singapore. Factors like rising healthcare expenditure, an aging population, longer life expectancy, and the increasing demand for point-of-care and home-based testing are boosting demand for membranes, conjugate pads, gold nanoparticles, and other LFA components. China and India remain the most influential markets due to their expanding healthcare infrastructure, rising incomes, and government focus on diagnostics. India's increased health budget for FY 2023-24 underscores this commitment. Meanwhile, Southeast Asian economies like Vietnam, Indonesia, and the Philippines are emerging as new growth centers, driven by strong GDP growth, increased manufacturing capacity, and foreign investment. Despite these growth drivers, challenges such as limited awareness of near-patient testing benefits, inadequate reimbursement structures, and infrastructural gaps in rural and remote areas pose barriers to full adoption. Nevertheless, the presence of competitive local manufacturers such as Advanced Microdevices Ltd. (India), J. Mitra & Co. (India), Nupore Filtration (China), and Equinox (China), alongside multinational suppliers, is strengthening the region's LFA component ecosystem and maintaining its position as the fastest-growing regional market.
Note 1: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the lateral flow assay components market are Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Ahlstrom (Finland), Advanced Microdevices Pvt. Ltd. (India), DCN Diagnostics (US), Fortis Life Sciences, LLC. (US), Cobetter (China), Axiva Sichem Pvt. Ltd. (India), and Nupore Filtration Systems (India).
Research Coverage
This report examines the lateral flow assay components market based on product, application, technique, end user, and region. It also evaluates factors such as drivers, restraints, opportunities, and challenges impacting market growth, and provides details about the competitive landscape of market leaders. Additionally, the report analyzes micro-markets concerning their individual growth trends. It forecasts the revenue of market segments across five major regions and their respective countries regions).
Reasons to Buy the Report
The report will help both established firms and smaller entrants assess the market, which can assist them in gaining a larger market share. Companies purchasing the report can utilize one or a combination of the strategies listed below to strengthen their market position presence.